Clinical Trials
- Sarcoma Cancers
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults with Soft Tissue Sarcomas (INVINCIBLE-3) (INVINCIBLE-3)
- Sarcoma Cancers
Testing Ipilimumab and Nivolumab Combination with or without Cabozantinib in People >= 18 Years Old with Advanced Soft Tissue Sarcoma
- Ages18 years and older
- GenderBoth
- Orthopaedics, Muscle & Bone
SSc Arm Fat Quantification Study